August 2022 formulary update - effective August 11, 2022
Included in the update:
Newsroom
The Issue: dimercaprol 300 mg vials have been discontinued in Canada.
Northern Health (NH) will be receiving a team of seven Accreditation Canada Surveyors between July 10-15, 2022 to complete the second half of our evaluation on Primary and Community Care & Population Health.
Resolution: Moxifloxacin 400 mg injectable is now available in good supply and this drug shortage can be considered resolved.
Date: June 10, 2022
The issue: hydrOXYzine 50 mg/mL injection is not currently available to order and ETA for resupply is unknown at this time. Based on historical use, NH has approximately 2 to 3 weeks of stock in pharmacies and wardstock locations.